We are thrilled to bring you three full days of CME/CE education from our expert thought leaders and moderators with our Summer of Lipids 2021 Meeting.  Each day will be filled with presentations, live Q&A sessions with our faculty, Expert Theaters, CME/CE Symposia and more.  By registering for this activity, you will receive continued access to the on-demand recordings of the lectures for 30 days following the meeting. We look forward to this exciting educational opportunity that will bring lipid specialists together from all around the world!

TARGETED AUDIENCE

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

EDUCATIONAL OBJECTIVES

• Recognize population differences that may impact clinical care.
• Appraise current and emerging management options for special populations with dyslipidemia.
• Describe best practices for using telemedicine in patient management.
• Discuss the efficacy and safety of hormonal therapies in the management of dyslipidemia and cardiovascular risk.
• Recognize gender differences in risk that impact clinical care to reduce cardiovascular disease.
• Describe the role of medical nutrition therapy in the treatment of dyslipidemia.
• Outline the impact of various diets on cardiovascular risks.
• Establish ACS risk management strategies that improve the care of women in primary and secondary prevention.
• Outline sex-specific risk factors for ACS.
• Establish criteria for the use of CAC scoring in the evaluation and classification of ACS risk in women.
• Compare the relative effectiveness of existing and emerging lipid altering therapies in ACS risk management in women.
• Critically appraise current clinical trials and methods.
• Discuss recent and ongoing clinical trials and their role in lipid and lipoprotein treatment in cardiovascular prevention.
• Identify implications of recent trials for clinical management of patients with genetic disorders.
• Describe barriers to effective recruiting of patients for clinical trials.
• Identify issues in the management of children with dyslipidemia.
• Determine opportunities for ensuring patients are well informed about treatment options for dyslipidemia.
• Evaluate the management of patients with dyslipidemia through case discussions.
• Discuss unique challenges to treatment of dyslipidemia from the patient’s perspective.
• Discuss recent research impacting the future management of patients with dyslipidemia.
• Discuss strategies to improve the knowledge, skills or performance of the healthcare team.
• Discuss efficient models of patient care, including operational issues, regulations, and referral strategies to run successful lipid clinics in various settings.
• Discuss the potential role of health information technology in optimizing lipid management.
• Discuss efficient models of outpatient care, including operational issues, regulations, and referral strategies to run successful lipid clinics in various settings.

ACCREDITATION

CME/CE credit provided by the National Lipid Association. This activity has been approved for AMA PRA Category 1 Credit™. This activity is eligible for ACPE, ANCC, and CDR credit.

To find out more please visit the official event page.